Dr. Willis joined EXUMA Biotechnology in 2018, where he is responsible for the company’s big data analytics programs as Senior Director of R&D Bioinformatics. From 2014 to 2018, Dr. Willis was Director of Computational Biology at the Avera Cancer Institute Center for Precision Oncology, responsible for the identification of prognostic and predictive genomic biomarkers in breast cancer clinical trials. While at Avera, he developed a genomic-centric EMR system to track a range of genomic tests used in supportive treatment plans for neo-adjuvant protocols. Dr. Willis is active in a range of emerging technologies focused on AI/Deep Learning to automate TIL calling to guide immunology treatment strategies in cancer. From 2012 to 2014, Dr. Willis was Director of Computational Bioinformatics at the Edith Sanford Breast Cancer Institute. From 2007 to 2012, Dr. Willis was a Data Analyst Scientist at Scripps Florida, where he developed software to automate the detection and identification of peptides in HDX Mass Spectrometry to interrogate protein structural dynamics to test the efficacy of drug candidates against target proteins. Dr. Willis earned his BSc in Electrical Engineering, Masters in Computer Science, MBA and Ph.D. in Computer Engineering from the University of Florida, where he also serves on the UFAA board of directors.
Scooter Willis, Ph.D.Senior Director, R&D Bioinformatics